The apurinic/apyrimidinic endonuclease (APE/ref-1) DNA repair enzyme is elevated in premalignant and malignant cervical cancer

Yi Xu, David H. Moore, John Broshears, Lifei Liu, Teresa M. Wilson, Mark R. Kelley

Research output: Contribution to journalArticle

82 Citations (Scopus)

Abstract

The multifunctional mammalian apurinic/apyrimidinic (AP) endonuclease (APE) is responsible for the repair of AP sites in DNA. In addition, this enzyme has been shown to function as a redox factor facilitating the DNA-binding capacity of JUN and FOS, HeLa AP-1, and numerous other transcription factors, including Myb, members of the CREB family and nuclear factor-κB. Although previously presumed to be ubiquitously expressed at comparable levels in all tissue and cell types, recent evidence has shown APE to vary significantly in its expression between tissues and even within tissues. To further characterize APE expression at various stages of cervical neoplasia, we investigated the levels of APE protein expression using immunohistochemistry in normal cervix, pre-invasive and invasive squamous lesions of the cervix, as well as in cervical cancer cell lines. We report here that the APE protein is predominantly expressed in the nuclei of cells from both primary tumours and cervical cell lines, but the level of APE protein is significantly and dramatically elevated in cervical cancer tissue. These results implicate the use of anti-APE antibodies as an effective reagent in the early detection of premalignant and malignant cancer of the cervix. These findings are suggestive that the increase of a DNA repair enzyme in cancerous cells may allow these cells to be refractive to chemotherapy.

Original languageEnglish (US)
Pages (from-to)3713-3719
Number of pages7
JournalAnticancer Research
Volume17
Issue number5 B
StatePublished - Sep 1 1997

Fingerprint

DNA-(Apurinic or Apyrimidinic Site) Lyase
DNA Repair Enzymes
Uterine Cervical Neoplasms
Cervix Uteri
Proteins
DNA
Tumor Cell Line
Cell Nucleus
Nuclear Family
Oxidation-Reduction
Transcription Factors
Immunohistochemistry
Drug Therapy
Cell Line
Antibodies
Enzymes

Keywords

  • APE/ref-1
  • DNA base excision repair
  • Immunohistochemistry

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

The apurinic/apyrimidinic endonuclease (APE/ref-1) DNA repair enzyme is elevated in premalignant and malignant cervical cancer. / Xu, Yi; Moore, David H.; Broshears, John; Liu, Lifei; Wilson, Teresa M.; Kelley, Mark R.

In: Anticancer Research, Vol. 17, No. 5 B, 01.09.1997, p. 3713-3719.

Research output: Contribution to journalArticle

Xu, Yi ; Moore, David H. ; Broshears, John ; Liu, Lifei ; Wilson, Teresa M. ; Kelley, Mark R. / The apurinic/apyrimidinic endonuclease (APE/ref-1) DNA repair enzyme is elevated in premalignant and malignant cervical cancer. In: Anticancer Research. 1997 ; Vol. 17, No. 5 B. pp. 3713-3719.
@article{827e626afd6a4bb78a3fe4f380424431,
title = "The apurinic/apyrimidinic endonuclease (APE/ref-1) DNA repair enzyme is elevated in premalignant and malignant cervical cancer",
abstract = "The multifunctional mammalian apurinic/apyrimidinic (AP) endonuclease (APE) is responsible for the repair of AP sites in DNA. In addition, this enzyme has been shown to function as a redox factor facilitating the DNA-binding capacity of JUN and FOS, HeLa AP-1, and numerous other transcription factors, including Myb, members of the CREB family and nuclear factor-κB. Although previously presumed to be ubiquitously expressed at comparable levels in all tissue and cell types, recent evidence has shown APE to vary significantly in its expression between tissues and even within tissues. To further characterize APE expression at various stages of cervical neoplasia, we investigated the levels of APE protein expression using immunohistochemistry in normal cervix, pre-invasive and invasive squamous lesions of the cervix, as well as in cervical cancer cell lines. We report here that the APE protein is predominantly expressed in the nuclei of cells from both primary tumours and cervical cell lines, but the level of APE protein is significantly and dramatically elevated in cervical cancer tissue. These results implicate the use of anti-APE antibodies as an effective reagent in the early detection of premalignant and malignant cancer of the cervix. These findings are suggestive that the increase of a DNA repair enzyme in cancerous cells may allow these cells to be refractive to chemotherapy.",
keywords = "APE/ref-1, DNA base excision repair, Immunohistochemistry",
author = "Yi Xu and Moore, {David H.} and John Broshears and Lifei Liu and Wilson, {Teresa M.} and Kelley, {Mark R.}",
year = "1997",
month = "9",
day = "1",
language = "English (US)",
volume = "17",
pages = "3713--3719",
journal = "Anticancer Research",
issn = "0250-7005",
publisher = "International Institute of Anticancer Research",
number = "5 B",

}

TY - JOUR

T1 - The apurinic/apyrimidinic endonuclease (APE/ref-1) DNA repair enzyme is elevated in premalignant and malignant cervical cancer

AU - Xu, Yi

AU - Moore, David H.

AU - Broshears, John

AU - Liu, Lifei

AU - Wilson, Teresa M.

AU - Kelley, Mark R.

PY - 1997/9/1

Y1 - 1997/9/1

N2 - The multifunctional mammalian apurinic/apyrimidinic (AP) endonuclease (APE) is responsible for the repair of AP sites in DNA. In addition, this enzyme has been shown to function as a redox factor facilitating the DNA-binding capacity of JUN and FOS, HeLa AP-1, and numerous other transcription factors, including Myb, members of the CREB family and nuclear factor-κB. Although previously presumed to be ubiquitously expressed at comparable levels in all tissue and cell types, recent evidence has shown APE to vary significantly in its expression between tissues and even within tissues. To further characterize APE expression at various stages of cervical neoplasia, we investigated the levels of APE protein expression using immunohistochemistry in normal cervix, pre-invasive and invasive squamous lesions of the cervix, as well as in cervical cancer cell lines. We report here that the APE protein is predominantly expressed in the nuclei of cells from both primary tumours and cervical cell lines, but the level of APE protein is significantly and dramatically elevated in cervical cancer tissue. These results implicate the use of anti-APE antibodies as an effective reagent in the early detection of premalignant and malignant cancer of the cervix. These findings are suggestive that the increase of a DNA repair enzyme in cancerous cells may allow these cells to be refractive to chemotherapy.

AB - The multifunctional mammalian apurinic/apyrimidinic (AP) endonuclease (APE) is responsible for the repair of AP sites in DNA. In addition, this enzyme has been shown to function as a redox factor facilitating the DNA-binding capacity of JUN and FOS, HeLa AP-1, and numerous other transcription factors, including Myb, members of the CREB family and nuclear factor-κB. Although previously presumed to be ubiquitously expressed at comparable levels in all tissue and cell types, recent evidence has shown APE to vary significantly in its expression between tissues and even within tissues. To further characterize APE expression at various stages of cervical neoplasia, we investigated the levels of APE protein expression using immunohistochemistry in normal cervix, pre-invasive and invasive squamous lesions of the cervix, as well as in cervical cancer cell lines. We report here that the APE protein is predominantly expressed in the nuclei of cells from both primary tumours and cervical cell lines, but the level of APE protein is significantly and dramatically elevated in cervical cancer tissue. These results implicate the use of anti-APE antibodies as an effective reagent in the early detection of premalignant and malignant cancer of the cervix. These findings are suggestive that the increase of a DNA repair enzyme in cancerous cells may allow these cells to be refractive to chemotherapy.

KW - APE/ref-1

KW - DNA base excision repair

KW - Immunohistochemistry

UR - http://www.scopus.com/inward/record.url?scp=0031439376&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031439376&partnerID=8YFLogxK

M3 - Article

C2 - 9427767

AN - SCOPUS:0031439376

VL - 17

SP - 3713

EP - 3719

JO - Anticancer Research

JF - Anticancer Research

SN - 0250-7005

IS - 5 B

ER -